Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Godinez v. Alere Inc. et al
Case Number:
1:16-cv-10766
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Abraham Fruchter
- Andrews DeValerio
- Bernstein Litowitz
- Block & Leviton
- Conn Kavanaugh
- Entwistle & Cappucci
- Goodwin Procter
- Hutchings Barsamian
- Kirkland & Ellis
- Labaton Keller
- Paul Weiss
- Robbins Geller
- Shapiro Haber
Companies
Sectors & Industries:
-
May 03, 2019
Abraham, Entwistle Seek $5.6M Atty Fees For Alere Deal
Abraham Fruchter & Twersky LLP and Entwistle & Cappucci LLP have asked a Massachusetts federal judge to order Alere Inc. to pay $5.6 million in attorney fees as part of a $20 million settlement in a proposed class action in which investors claimed the company lied about its blood monitoring system.
-
February 01, 2019
Alere Settles Investor Claims Over Blood Monitor For $20M
Alere Inc. struck a $20 million deal with its investors to resolve claims that it allegedly lied about its blood-monitoring system and caused share price upheaval ahead of its proposed multibillion-dollar acquisition by Abbott Laboratories in 2016, according to a settlement proposed in Massachusetts federal court on Thursday.
-
July 02, 2018
Abbott Must Look Again For Docs Sought By Alere Investors
Abbott Laboratories must check again for emails that a purported class of Alere Inc. investors believe will illustrate whether it lied about its blood-monitoring system and caused a stock-price rollercoaster leading up to the companies' multibillion-dollar merger in 2016, a Massachusetts federal judge ordered in court Monday.
-
April 19, 2018
Abbott Must Give Docs To Alere Investors In Stock-Drop Suit
Abbott Laboratories must relay four months' worth of merger discussions to a proposed class of Alere Inc. investors suing Alere over a dip in its stock price while the companies were negotiating a $5.3 billion merger in 2016, a federal magistrate judge ruled on Thursday in a Boston courtroom.
-
January 12, 2018
Investors Want Abbott To Explain Delay In Alere Deal
Abbott Laboratories must turn over documents related to its motive for balking at and then renegotiating its $5.3 billion purchase of Alere Inc., Alere investors said Thursday in Massachusetts federal court, arguing that Abbott's reasoning is key to their stock drop lawsuit against Alere.
-
August 23, 2017
Alere Escapes Most, But Not All, Of Securities Class Action
Medical diagnostic equipment maker Alere Inc. won the dismissal of most of a securities fraud class action on Wednesday, with a Massachusetts federal judge concluding that there was little to support the idea that Alere's bosses knew about most of its alleged wrongdoing.
-
September 26, 2016
Alere Hit With New Complaint Over $5.8B Abbott Merger
Shareholders in a proposed class action against Alere Inc. filed a consolidated complaint in Massachusetts federal court on Friday, accusing the company of withholding information about its internal controls and a federal probe into its dealings as it tried to push through a troubled $5.8 billion merger with Abbott Laboratories.